Treatment for Roundworm (Ascaris lumbricoides)
Treat roundworm infection with a single dose of albendazole 400 mg PO, mebendazole 500 mg PO, or ivermectin 200 μg/kg PO 1.
First-Line Treatment Options
Based on the most recent 2025 UK guidelines for eosinophilia management, all three medications are equally effective as single-dose therapy 1:
- Albendazole 400 mg PO (single dose)
- Mebendazole 500 mg PO (single dose)
- Ivermectin 200 μg/kg PO (single dose)
These recommendations are supported by high-certainty evidence showing no meaningful differences between these agents in terms of parasitological cure or adverse events 2.
Treatment Efficacy
All three anthelmintics demonstrate excellent efficacy against Ascaris:
- Parasitological cure rates: 87.8-98.0% across all agents 2
- Egg reduction rates: 96-100% regardless of drug used 2
- Failure rates: Very low (0.0-30.3% for albendazole, 0.0-22.2% for mebendazole, 0.0-21.6% for ivermectin) 2
Recent 2026 data from Ethiopia confirms albendazole maintains 92.3% cure rate and 96.7% egg reduction rate, well within WHO satisfactory levels 3. Similarly, 2025 data shows both Vermox® and generic mebendazole brands achieve >90% cure rates against Ascaris 4.
Special Populations
Pregnant women: Use pyrantel pamoate instead of albendazole or mebendazole 5, 6. The benzimidazoles (albendazole/mebendazole) should be avoided in pregnancy, particularly first trimester.
Children: Same dosing as adults applies for children >24 months. For children 12-24 months, discuss with an expert before treatment 1.
Clinical Presentation Context
Most Ascaris infections are asymptomatic 1. When symptomatic, patients present with:
- Abdominal pain and diarrhea
- Gastrointestinal obstruction (children) or biliary obstruction (adults)
- Visible earthworm-sized pink/white worms in stool or regurgitated
- Acute Loeffler's syndrome (pulmonary phase with fever, urticaria, wheeze, cough during larval lung migration) 1
For Loeffler's syndrome: Consider empirical treatment with single-dose ivermectin 200 μg/kg plus albendazole 400 mg if no organism identified, with retreatment 1 month after symptom resolution 1.
Important Caveats
Reinfection is common: Even with >95% cure rates, patients in endemic areas frequently become reinfected within months 6. The 2026 Ethiopian study documented 34.7% reinfection rate at 3 months post-treatment 3. Poor latrine utilization and inadequate fingernail trimming practices significantly increase reinfection risk 3.
Treatment alone is insufficient: Effective long-term control requires combining drug treatment with improved sanitation, health education, and proper hygiene practices 6, 3.
Exclude Loa loa before ivermectin: In patients who have traveled to Loa loa endemic regions (Central/West Africa), exclude loiasis before administering ivermectin to prevent severe neurological adverse events 1.
Adverse Events
All three anthelmintics are safe with similar adverse event profiles 2. Commonly reported effects include nausea, vomiting, abdominal pain, diarrhea, headache, and fever—none serious 2.